D'après la communication de : JF Moctezuma, C Pacheco-Tena, MA Gonzalez, G Medrano, C Garcia, R Burgos-Vargas Mexico, DF, Mexico [Abstract 1898] EFFICACY AND TOLERANCE A EVERY OTHER WEEK (EOW) INTRAMUSCULAR METHOTREXATE (EOW-IM-MTX) REGIME IN PATIENTS WITH RHEUMATOID ARTHRITIS (FOLLOWED FOR ONE YEAR). Rapporté par Philippe Brissaud, Paris

D'après la communication de : Hanne Merete Lindegaard, Kim Horslev-Petersen, Bo Abrahamsen, Peter Junker [Abstract 1346] APPENDICULAR AND GENERALIZED BONE LOSS IN RA OF RECENT ONSET - A ONE YEAR PROSPECTIVE STUDY. Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

D'après la communication de : Beatriz E Joven, Raquel Almodovar, Rafael Salguero, Alfredo Llovet, Patricia E Carreira Madrid, Spain [Abstract 1920] CHLOROQUINE RELATED CARDIAC TOXICITY: A NOT SO RARE COMPLICATION. Rapporté par Philippe Brissaud, Paris

D'après la communication de : D E Furst, S Cohen, P Emery, K Dorrier, K Simpson Seattle, WA; Dallas, TX; Leeds, UK; Arlington, VA and Bridgewater, NJ [Abstract 1921] DOES FOLIC ACID (FA) DECREASE THE EFFICACY AS WELL AS THE TOXICITY OF METHOTREXATE (MTX) IN RHEUMATOID ARTHRITIS (RA)? Rapporté par Philippe Brissaud, Paris

D'après la communication de : Jacques R Caldwell, Howard Offenberg, Daniel Furst, Nancy P Lam, Gerald Jayne, Tenshang Joh, Mark W Davis, Carl K Edwards III Gainesville and Daytona Beach, FL; Seattle, WA and Thousand Oaks, CA [Abstract 1904] A PHASE I SAFETY STUDY OF COMBINATION TREATMENT WITH PEGYLATED SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TYPE I (PEG sTNF-RI) AND ANAKINRA (INTERLEUKIN-1 RECEPTOR ANTAGONIST, IL-1RA) IN PATIENTS WITH RHEUMATOID ARTHRITIS. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Duboeuf Francois, Charrin Jeanne, Noel Eric, Le Luherne Yannick, Delmas Pierre, Meunier Pierre Lyon, Cedex 03, France [Abstract 1236] DECREASE OF BONE DENSITY IN FROZEN SHOULDER. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Gunnel Nordmark, Fredrik Rorsman, Lars Ronnblom, Stefan Cajander, Michael Taussig, Olle Kampe, Ola Winqvist [Abstract 1209] CLINICAL CORRELATIONS OF a-FODRIN AUTOANTIBODIES DETECTED BY IN VITRO TRANSCRIPTION AND TRANSLATION IN PRIMARY SJOGRENS SYNDROME AND SLE. Rapporté par Philippe Brissaud, Paris

D'après la communication de : L Radfar, M Kok, D Kleiner, L Sorbara, M Raffeld, S Pillemer Bethesda, Maryland [Abstract 1206] PREDICTION OF MONOCLONAL B-CELL EXPANSION IN SJOGREN’S SYNDROME. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Xavier Mariette, Sophie Roux, Frederic Desmoulins, Jacques-Eric Gottenberg, Jun Zhang, Tong Zhou, Robert P Kimberly Le Kremlin Bicetre, France and Birmingham, AL [Abstract 1205] A ROLE FOR B LYMPHOCYTE STIMULATOR (BLYS) IN SJOGREN'S SYNDROME. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Baya Benyahia, Zahir Amoura, Audrey Rousseau, Christelle Leclanche, Antoine Carpentier, Jean-Charles Piette, Jean-Yves Delattre Paris, France [Abstract 917] PARANEOPLASTIC ASSOCIATED ANTINEURONAL ANTIBODIES IN PATIENTS WITH PRIMARY SJOGREN'S SYNDROME OR SYSTEMIC LUPUS ERYTHEMATOSUS. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Dimitris Mitsias, Athanasios G Tzioufas, Christina Veiopoulou, Haralampos M Moutsopoulos, George Thyphronitis Athens, Greece [Abstract 1202] TH1/TH2 IMBALANCE IN AUTOIMMUNE SIALADENITIS OF SJOGREN'S SYNDROME. Rapporté par Philippe Brissaud, Paris

D'après la communication de : Bjorn Hostmann, Rolf Klein, Velia Ruppert, Christa Johnen, Svenja Sethmann, Falk Hiepe Berlin, Germany [Abstract 906] EFFECT OF TNF-a ON THE mRNA EXPRESSION OF THE 52KD RO/SSA AUTOANTIGEN IN HUMAN KERATINOCYTES. Rapporté par Philippe Brissaud, Paris